Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- seladelpar
- Tafinlar (dabrafenib)
Interactions between your drugs
dabrafenib seladelpar
Applies to: Tafinlar (dabrafenib), seladelpar
Dabrafenib may reduce the blood levels of seladelpar, which could make the medication less effective. Your healthcare provider may already be aware of the risks, but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
dabrafenib food/lifestyle
Applies to: Tafinlar (dabrafenib)
Food may delay and reduce the absorption of dabrafenib, which may lead to lower blood levels of the medication and possibly reduced effectiveness. You should take dabrafenib at least 1 hour before or 2 hours after a meal.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Livdelzi
Livdelzi (seladelpar) is an oral prescription medicine that may be used to treat primary biliary ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Actigall
Actigall is used for gallbladder disease, primary biliary cholangitis
Ocaliva
Ocaliva may be used to treat primary biliary cholangitis (PBC) in adults without cirrhosis or with ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Urso Forte
Urso Forte is used for gallbladder disease, primary biliary cholangitis
Reltone
Reltone is used for gallbladder disease, primary biliary cholangitis
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Obeticholic acid
Obeticholic acid (brand name Ocaliva) may be used to treat primary biliary cholangitis (PBC) in ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.